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CONTINUOUS HEMOFILTRATION (HF) is widely used for renal re­
placement therapy in patients who develop kidney failure as part of a 
multiple organ dysfunction syndrome (MODS). In these patients we dem­
onstrated a correlation between the daily amount of ultrafiltrate and the 
survival rate.1 It has been suggested that HF may eliminate toxic mediators 
of MODS. 2 The present study examined whether HF can activate or elim­
inate established mediators in patients with septic MODS. Because the 
exact nature of the factors removed remains unclear, it appeared feasible 
to evaluate the biological effect of ultrafiltrate by exposing it to several 
white blood cell subfractions in vitro. 
MATERIALS AND METHODS 
Continuous isovolemic veno-venous HF was performed using a fiber 
hemofilter (FH 66, Gambro, Hechingen, FRG) and a flow-controlled roller 
pump (filtration rate: 2 L/min) in 16 patients with septic MODS (Elebute 
and Stoner3 scorepoints ^20) and in five healthy volunteers. Pre- and post-
filter and ultrafiltrate concentrations of cytokines (interleukin [IL]-lß, IL-6, 
IL-8, tumor necrosis factor [TNF]-a) and of complement compounds (C3, 
C3a, C5a, C5b-9) were measured shortly after the beginning of HF (to) and 
60 minutes later (t^). Healthy peripheral blood mononuclear cells (PBMC) 
and lymphocytes were incubated with ultrafiltrate and stimulated with en-
dotoxin and phytohemagglutinin (PHA), respectively. Cell function was de-
termined by measuring concentrations of several released cytokines in the 
supernatants and by PHA (0.5 μg/mL)-induced 3H-thymidine uptake. Iso­
tonic saline solution (NaCl) served as control. A l l data are expressed as 
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Table 1—TNF, IL-6, and IL-1 release of human peripheral blood mononuclear cells (PBMC) and IL-2 and IL-6 
release of lymphocytes in vitro 
Septic patients (n = 16) Healthy volunteers (n = 5) 
Ultrafiltrate Ultrafiltrate Ultrafiltrate Ultrafiltrate 
PBMC at ^ at tM NaCI controls at ^ at tM NaCl controls 
TNF (U/mL) 41.0 ± 10.0t 40.2 ± 10.7t 12.8 ± 4.3 26.5 ± 8.6 31.2 ± 12.1 23.8 7.8 
IL-6 (U/mL) 2,015 ± 466 1,485 ± 244 2,006 ± 255 1,518 ± 212 1,471 ± 294 1,398 ± 175 
IL-1 (pg/mL) 966 256 n.d. 946 ± 183 935 ± 211 n.d. 936 ± 173 
Lymphocytes 
IL-2 (U/mL) 0.35 0.07t n.d. 0.66 ± 0.07 0.48 ± 0.18 n.d. 0.41 ± 0.12 
IL-6 (U/mL) 4,295 896* 3,093 ± 741 f 6,496 ± 873 5,879 ± 2,670 5,316 ± 1,833 5,433 ± 1,497 
Cultures were costimulated with endotoxin (1 μ^ηι ί ) and phytohemagglutinin (2.5 μg/mL), respectively. Cells were incubated with septic or 
healthy ultrafiltrate collected at t0 and t^ ,. Ultrafiltrate and corresponding NaCl incubations were always performed in the same cell preparation. 
*P < 0.01 vs. NaCl; < 0.001 vs. NaCl; n.d. = not determined. 
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mean ± SEM. The differences between the incubation procedures and 
between means of different time points were compared with the Student's 
Mest. A significance level of Ρ = 0.01 was used throughout the study. 
RESULTS 
HF showed no signs of mediator activation, since the most sensitive 
parameter (pre/postfilter C5b-9 concentration difference) remained un­
changed during treatment. Prefilter concentrations of cytokines were con­
stant during HF, although IL-1 and IL-8 were detected in the ultrafiltrate. 
Prefilter C3a concentration significantly declined during HF (patients: Xx 
= 676.9 ± 99.7 ng/mL, t 2 = 545.4 ± 83.2, Ρ < 0.001; volunteers: t t = 
54.82 ± 13.25 ng/mL, t 2 = 33.9 ± 10.68, Ρ < 0.001) and C3a appeared 
in ultrafiltrates. Septic ultrafiltrate enhanced endotoxin-induced TNF-α re­
lease in PBMC and suppressed PHA-induced lymphocyte IL-2 and IL-6 
production (Table 1). PBMC proliferation was suppressed by septic ul­
trafiltrate compared to NaCl (septic ultrafiltrate at 14,754 ± 1,534 cpm 
vs. NaCl: 37,418 ± 160 cpm; Ρ < 0.001). Ultrafiltrate from volunteers 
did not cause significant changes. 
CONCLUSIONS 
Blood-membrane contact during hemofiltration does not appear to ac­
tivate mediators of MODS. Certain factors such as C3a, but not established 
cytokines, are effectively eliminated by HF. Ultrafiltrate from patients with 
MODS contains a mixture of mediators, which induces changes in healthy 
white blood cell function with similarity to the septic response. HF rep­
resents a new modality of mediator removal in situations calling for an 
attenuation of an exaggerated monocyte TNF production and a stimulation 
of suppressed lymphocyte function. 
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